82 FR 22337 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 82, Issue 92 (May 15, 2017)

Page Range		22337-22337
FR Document		2017-09710

Federal Register, Volume 82 Issue 92 (Monday, May 15, 2017)

[Federal Register Volume 82, Number 92 (Monday, May 15, 2017)]
[Notices]
[Page 22337]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-09710]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to PAR 13-129, Occupational Safety and Health 
Research, NIOSH Member Conflict Review.
    Times and Dates: 1:00 p.m.-4:00 p.m., EDT, June 8, 2017 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``NIOSH Member Conflict Review'', PAR 13-129.
    Contact Person for More Information: Nina Turner, Ph.D., Scientific 
Review Officer, NIOSH, CDC, 1095 Willowdale Road, Mailstop G905, 
Morgantown, West Virginia 26506, Telephone: (304) 285-5976.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2017-09710 Filed 5-12-17; 8:45 am]
BILLING CODE 4163-18-P

Federal Register / Vol. 82, No. 92 / Monday, May 15, 2017 / Notices 22337

or services to improve population settings. The estimated workload for Prevention and the Agency for Toxic
health. CPSTF members is approximately 168 Substances and Disease Registry.
Strongest consideration will be given hours a year in addition to the three in- Elaine L. Baker,
to individuals with expertise and person meetings. The members are all
experience: Director, Management Analysis and Services
volunteers and do not receive any Office, Centers for Disease Control and
• That is applied, with practical compensation beyond support for travel Prevention.
applications for public health action; to in-person meetings.
• That addresses broad public health [FR Doc. 2017–09710 Filed 5–12–17; 8:45 am]
considerations, or is beyond one or two Dated: May 10, 2017. BILLING CODE 4163–18–P

highly defined areas; and Lauren Hoffmann,
• In state and/or local health Acting Executive Secretary, Centers for
departments. DEPARTMENT OF HEALTH AND
Disease Control and Prevention. HUMAN SERVICES
In the current round of nominations, [FR Doc. 2017–09733 Filed 5–12–17; 8:45 am]
the strongest consideration will also be Centers for Disease Control and
BILLING CODE 4163–18–P
given to people with expertise and Prevention Advisory
experience in systematic review
methods, economic analysis, injury (in DEPARTMENT OF HEALTH AND Committee on Immunization Practices
particular substance abuse and violence
HUMAN SERVICES In accordance with section 10(a)(2) of
prevention), aging, and rural health. The
CPSTF will also benefit from members the Federal Advisory Committee Act
Centers for Disease Control and (Pub. L. 92–463), the Centers for Disease
with expertise and experience in the Prevention
following areas: Minority health; Control and Prevention (CDC) announce
worksite health; military health and the following meeting of the
Disease, Disability, and Injury aforementioned committee.
readiness; and health media, Prevention and Control Special
communications and marketing. Times and Dates:
Emphasis Panel (SEP): Initial Review 8:30 a.m.–5:35 p.m., EDT, June 21, 2017
Candidates with experience and skills
in any of these areas should highlight 8:00 a.m.–1:00 p.m., EDT, June 22, 2017
In accordance with Section 10(a)(2) of
them in their nomination materials. Place: CDC, Tom Harkin Global
the Federal Advisory Committee Act Communications Center, 1600 Clifton
All nominated individuals will be (Pub. L. 92–463), the Centers for Disease
considered for CPSTF membership. Road NE., Building 19, Kent ‘‘Oz’’
Control and Prevention (CDC) Nelson Auditorium, Atlanta, Georgia
Applicants must have no substantial
conflicts of interest, whether financial, announces a meeting for the initial 30329.
professional, or intellectual, that would review of applications in response to Status: Open to the public, limited
impair the scientific integrity of the PAR 13–129, Occupational Safety and only by the space available. Time will
work of the CPSTF and must be willing Health Research, NIOSH Member be available for public comment. The
to complete regular conflict of interest Conflict Review. public is welcome to submit written
disclosures. Times and Dates: 1:00 p.m.–4:00 p.m., comments in advance of the meeting.
Applicants must have the ability to EDT, June 8, 2017 (Closed). Comments should be submitted in
work collaboratively with a team of writing by email to the contact person
Place: Teleconference. listed below. The deadline for receipt is
diverse professionals who support the
mission of the CPSTF. Applicants must Status: The meeting will be closed to June 12, 2017. All requests must contain
have adequate time to contribute the public in accordance with the name, address, and organizational
substantively to the work products of provisions set forth in Section 552b(c) affiliation of the speaker, as well as the
the CPSTF. (4) and (6), Title 5 U.S.C., and the topic being addressed. Written
Determination of the Director, comments should not exceed one single-
Nominee Selection spaced typed page in length and
Management Analysis and Services
Appointments to the CPSTF will be Office, CDC, pursuant to Public Law 92– delivered in 3 minutes or less. Please
made on the basis of qualifications as 463. note that the public comment period
outlined above (see Qualification may end before the time indicated,
Matters for Discussion: The meeting
Requirements) and the current expertise following the last call for comments.
needs of the CPSTF. will include the initial review, Members of the public who wish to
discussion, and evaluation of provide public comments should plan
Time Commitment applications received in response to to attend the public comment session at
The CPSTF conducts three, two-day ‘‘NIOSH Member Conflict Review’’, PAR the start time listed. Written comments
meetings each year that are open to the 13–129. received in advance of the meeting will
public. In addition, a significant portion Contact Person for More Information: be included in the official record of the
of the CPSTF’s work occurs between Nina Turner, Ph.D., Scientific Review meeting.
meetings during conference calls and Officer, NIOSH, CDC, 1095 Willowdale The meeting will be webcast live via
via email discussions. Member duties Road, Mailstop G905, Morgantown, the World Wide Web; for instructions
include overseeing the process of West Virginia 26506, Telephone: (304) and more information on ACIP please
prioritizing Task Force work, 285–5976. visit the ACIP Web site: http://
participating in the development and
jstallworth on DSK7TPTVN1PROD with NOTICES

www.cdc.gov/vaccines/acip/index.html.
refinement of systematic review The Director, Management Analysis Purpose: The committee is charged
methods, serving as members of and Services Office, has been delegated with advising the Director, CDC, on the
individual review teams, and issuing the authority to sign Federal Register use of immunizing agents. In addition,
recommendations and findings to help notices pertaining to announcements of under 42 U.S.C. 1396s, the committee is
inform the decision making process meetings and other committee mandated to establish and periodically
about policy, practice, research, and management activities, for both the review and, as appropriate, revise the
research funding in a wide range of U.S. Centers for Disease Control and list of vaccines for administration to

VerDate Sep<11>2014 13:51 May 12, 2017 Jkt 241001 PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 E:\FR\FM\15MYN1.SGM 15MYN1

Document Created: 2017-05-13 02:38:49
Document Modified: 2017-05-13 02:38:49

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		1:00 p.m.-4:00 p.m., EDT, June 8, 2017 (Closed).
FR Citation		82 FR 22337

82 FR 22337 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 82, Issue 92 (May 15, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention